Report
Jake Strole

The More Things Change the More They Stay The Same: Takeaways From Teleflex's Investor Day

Teleflex hosted an investor day on May 11 to provide a deep dive into the firm’s business segments, and to outline management’s multiyear outlook for the company. Based on what we heard, we expect few changes at the firm over the coming years and plan no changes to our no-moat rating and $185 fair value estimate. This was CEO Liam Kelly's first major platform to lay out his goals and set the course for Teleflex under his leadership. Our sense is that the firm's strategy under Kelly will remain l...
Underlying
Teleflex Incorporated

Teleflex is a provider of medical technology products. The company primarily designs, develops, manufactures and supplies single-use medical devices used by hospitals and healthcare providers for common diagnostic and therapeutic procedures in critical care and surgical applications. The company's product categories within its geographic segments include vascular access, which provides devices that facilitate a variety of critical care therapies and other applications; anesthesia, which comprised of airway and pain management product lines; and interventional, which consist of a variety of coronary catheters, structural heart therapies, and peripheral intervention products.

Provider
Morningstar
Morningstar

Morningstar, Inc. is a leading provider of independent investment research in North America, Europe, Australia, and Asia. The company offer an extensive line of products and services for individual investors, financial advisors, asset managers, and retirement plan providers and sponsors.

Morningstar provides data on approximately 530,000 investment offerings, including stocks, mutual funds, and similar vehicles, along with real-time global market data on more than 18 million equities, indexes, futures, options, commodities, and precious metals, in addition to foreign exchange and Treasury markets. Morningstar also offers investment management services through its investment advisory subsidiaries and had approximately $185 billion in assets under advisement and management as of June 30, 2016.

We have operations in 27 countries.

Analysts
Jake Strole

Other Reports on these Companies
Other Reports from Morningstar

ResearchPool Subscriptions

Get the most out of your insights

Get in touch